• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

Gut Infections Nearly Double the Odds of Childhood Stunting, Global Meta-Analysis Finds

Bioengineer by Bioengineer
September 27, 2026
in Technology
Reading Time: 6 mins read
0
Gut Infections Nearly Double the Odds of Childhood Stunting, Global Meta-Analysis Finds
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Childhood stunting remains one of the most stubborn markers of global health inequality, and a new systematic review and meta-analysis published in Pediatric Research has sharpened the picture of what drives it. The study, led by Rizqi Yanuar Pauzi of Universitas Jenderal Soedirman in Indonesia, set out to answer a deceptively simple question: how strongly are laboratory-confirmed enteric infections associated with stunting in children, and does the answer depend on whether the culprit is a bacterium, a virus, a protozoan, or a helminth? The conclusion is striking in both its clarity and its caution. Across fourteen independent studies pooling data from thousands of children, any enteric infection was associated with nearly double the odds of stunting, an odds ratio of 1.94 with a 95 percent confidence interval of 1.33 to 2.82. Yet the authors also graded the certainty of that evidence as very low, a reminder of how difficult it is to isolate a single biological cause in the tangled web of poverty, nutrition, and infection.

The methodology behind the analysis reflects the modern standards of evidence synthesis. The research team searched MEDLINE through PubMed, Embase, Scopus, and Web of Science from database inception to July 2026, casting a wide net for observational studies that evaluated laboratory-confirmed enteric infections against stunting outcomes in children. Nineteen studies passed the quality threshold for the qualitative synthesis, and fourteen contributed effect estimates to the quantitative meta-analysis. The authors followed the PRISMA 2020 reporting guidelines, pooled odds ratios using random-effects models, and assessed risk of bias with the Newcastle–Ottawa Scale. Certainty of evidence was judged using the GRADE framework, the same structured approach that underpins World Health Organization guideline development. This combination of transparent searching, formal bias assessment, and pre-specified subgroup analyses gives the review a methodological rigor that many entries in the stunting literature have lacked.

The headline number deserves unpacking. An odds ratio of 1.94 means that children with laboratory-confirmed enteric infections had roughly 94 percent higher odds of being stunted, defined as height-for-age more than two standard deviations below the reference median, compared with children without such infections. That is a substantial association in a field where effect estimates often hover close to unity. But the pooled figure came with an I-squared statistic of 85.6 percent, indicating that more than eight-tenths of the variability among studies reflected real differences between populations and methods rather than random noise. In practical terms, the pooled odds ratio describes an average of a highly heterogeneous body of evidence, and the authors were careful not to oversell it. Heterogeneity of this magnitude is common in observational meta-analyses of infection and nutrition, where study settings range from urban slums to rural highlands and diagnostic tools range from microscopy to multiplex PCR.

To probe that heterogeneity, the team conducted pre-specified subgroup analyses across pathogen domains: bacterial, viral, protozoal, helminthic, and non-specific parasitic infections. The most consequential finding of the review may be what did not emerge. Despite wide differences in the biology of these organisms, the associations with stunting were broadly comparable across domains, with no statistically significant differences between pathogen groups. Bacteria such as enteroaggregative Escherichia coli, viruses such as rotavirus, protozoa such as Giardia and Cryptosporidium, and soil-transmitted helminths all appeared to leave children at similar elevated risk of growth faltering. The authors interpret this convergent pattern as evidence that multiple enteric pathogens may impair child growth through shared biological pathways rather than through pathogen-specific mechanisms.

That interpretation aligns with two decades of research into environmental enteric dysfunction, a subclinical condition of the small intestine that has become a central hypothesis in child growth biology. Repeated exposure to fecal pathogens is thought to provoke chronic mucosal inflammation, villous atrophy, increased intestinal permeability, and malabsorption, collectively blunting the child’s ability to convert food into linear growth. Studies cited in the review, including the Environmental Enteric Dysfunction Biopsy Initiative and work linking the condition to carnitine deficiency and altered fatty acid oxidation, describe a gut that is chronically inflamed and metabolically compromised even in children who never present with overt diarrhea. Chronic inflammation also suppresses the growth hormone–insulin-like growth factor-1 axis, the endocrine engine of linear growth, providing a plausible mechanistic bridge from a fecal-contaminated environment to a stunted child.

Meta-regression added a second layer of insight by identifying participant age and adjustment status as significant sources of between-study heterogeneity. The association between enteric infection and stunting was strongest among children younger than two years, which the authors read as a signal about the first 1000 days of life, the window from conception through roughly the second birthday during which linear growth velocity is highest and the developing gut and immune system are most vulnerable to disruption. This timing matters for intervention design. A child whose gut is repeatedly infected during the period of most rapid growth may sustain deficits that nutritional supplementation later in childhood cannot fully reverse, echoing longitudinal findings from the MAL-ED birth cohort across eight low- and middle-income country sites, which documented that even asymptomatic enteropathogen infections measurably depressed linear growth.

The finding that statistical adjustment for confounders shaped the observed effect estimates is equally important for readers interpreting the evidence. Observational studies of infection and stunting must contend with a dense thicket of confounding: household wealth, maternal education, water and sanitation access, breastfeeding practices, and diet all influence both infection risk and growth. Studies that adjusted more comprehensively for these factors produced different effect estimates than those that did not, and the meta-regression captured this as a source of heterogeneity. The very low GRADE rating applied to the pooled evidence reflects these inherent limitations. Association is not causation, reverse causality remains possible, since malnourished children may be more susceptible to infection as well as more harmed by it, and the Review authors are explicit that their pooled estimate should guide hypothesis formation and intervention priority-setting rather than be read as a precise causal coefficient.

The geographical scope of the underlying studies, spanning Ethiopia, Bangladesh, Indonesia, Peru, Zambia, Madagascar, the Philippines, Zimbabwe, and other low- and middle-income settings, underscores that the stunting–infection relationship is concentrated where sanitation infrastructure is weakest. Several included studies examined the interaction between enteric infections and environmental enteric dysfunction directly, and others evaluated how water, sanitation, and hygiene interventions perform in children carrying different pathogen burdens. Collectively, this literature suggests that the classic nutrition-centric framing of stunting, in which food insecurity is treated as the dominant driver, captures only part of the story. A child can consume adequate calories and still fail to grow if a chronically inflamed gut cannot absorb them.

For policymakers, the practical implications of the review are captured in its stated impact summary: the findings support integrating infection prevention, sanitation, and nutritional interventions into child stunting reduction programs, rather than pursuing these strategies in silos. That means pairing supplementary feeding and dietary diversification with safe water, improved sanitation, deworming where helminth burden is high, and, where available, vaccination against enteric pathogens. The absence of differences between pathogen domains complicates any pathogen-by-pathogen targeting strategy and instead argues for broad environmental measures that reduce exposure to the fecal–oral pathway as a whole. The vulnerability of children under two further suggests that interventions should begin in pregnancy and infancy, when the marginal return on preventing gut disruption is highest.

The review, published on 26 September 2026 with the DOI 10.1038/s41390-026-05520-4, arrives at a moment when the global health community is assessing why stunting prevalence has declined more slowly than under-five mortality. By quantifying a roughly twofold elevation in stunting odds associated with enteric infections across bacterial, viral, protozoal, and helminthic domains, and by flagging the first 1000 days as the period of maximal vulnerability, it offers both a synthesis of a fragmented literature and a clear agenda for what must come next: longitudinal studies with molecular diagnostics, better confounder control, and intervention trials that test whether breaking the infection–inflammation cycle unlocks growth that nutrition alone cannot deliver. The evidence may be graded very low in certainty, but the direction of the signal, and the scale of the population at risk, give it a weight that few will ignore.

Subject of Research: The association between enteric infections across four pathogen domains and childhood stunting in low- and middle-income countries

Article Title: Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains

Article References: Pauzi, R. Y., Iqhrammullah, M., Ihtiaringtyas, S., Ilmi, A. N., Kumaratih, L. W., Yuliana, P. T., Aqila, R. A., & Raizma, E. Z. N. (2026). Enteric infections and childhood stunting: a systematic review and meta-analysis across four pathogen domains. Pediatric Research. https://doi.org/10.1038/s41390-026-05520-4

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05520-4

Keywords: childhood stunting, enteric infections, meta-analysis, systematic review, environmental enteric dysfunction, gut microbiology, pediatric growth, first 1000 days, soil-transmitted helminths, water sanitation and hygiene, low- and middle-income countries, GRADE evidence

Cite Scienmag News
APA MLA Chicago

Denise Maddox. (September 27, 2026). Gut Infections Nearly Double the Odds of Childhood Stunting, Global Meta-Analysis Finds. Scienmag. https://scienmag.com/gut-infections-nearly-double-the-odds-of-childhood-stunting-global-meta-analysis-finds/

Denise Maddox. “Gut Infections Nearly Double the Odds of Childhood Stunting, Global Meta-Analysis Finds.” Scienmag, 27 September 2026, https://scienmag.com/gut-infections-nearly-double-the-odds-of-childhood-stunting-global-meta-analysis-finds/. Accessed 27 September 2026.

Denise Maddox. “Gut Infections Nearly Double the Odds of Childhood Stunting, Global Meta-Analysis Finds.” Scienmag. September 27, 2026. https://scienmag.com/gut-infections-nearly-double-the-odds-of-childhood-stunting-global-meta-analysis-finds/

Copy citation Download RIS

Tags: childhood growth and gastrointestinal healthchildhood stuntingenteric infectionsenvironmental enteric dysfunctionevidence certainty in health studiesfirst 1000 daysglobal health inequalityGRADE evidencegut infectionsgut microbiologyimpact of bacteria and viruses on child growthinfectious causes of malnutritionlow-and-middle-income countriesmeta-analysismeta-analysis of pediatric healthodds ratio of stunting associated with infectionspediatric growthprotozoan and helminth infectionssoil-transmitted helminthssystematic reviewsystematic review methodologywater sanitation and hygiene

Share12Tweet7Share2ShareShareShare1

Related Posts

Screens, Seconds and Faces: New Study Probes Why Test Scores Mislead

Screens, Seconds and Faces: New Study Probes Why Test Scores Mislead

September 27, 2026
Robot Therapies for Autistic Children Face a Hard Ethical Reckoning

Robot Therapies for Autistic Children Face a Hard Ethical Reckoning

September 27, 2026

How a Plant Hormone Switches On Immunity: New Clues From Salicylic Acid Receptors

September 27, 2026

AI Model Watches Bitcoin’s Underworld as Illicit Transactions Evolve Into Hidden Networks

September 27, 2026

POPULAR NEWS

  • When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

    29 shares
    Share 12 Tweet 7
  • Vitamin D Receptor Gene Variants Tied to Diabetic Foot Ulcer Risk in Kerala Study

    29 shares
    Share 12 Tweet 7
  • Weight-Loss Drugs Are Redrawing the Map of Sleep Medicine

    29 shares
    Share 12 Tweet 7
  • Approved Metabolism Drugs Rescue Disease Signs in SMA Mice

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

Vitamin D Receptor Gene Variants Tied to Diabetic Foot Ulcer Risk in Kerala Study

Weight-Loss Drugs Are Redrawing the Map of Sleep Medicine

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.